麻豆传媒

SUMMIT trial able to show clinical benefit beyond quality-of-life improvement

Also in TTHealthWatch: frailty as a predictor of dementia

Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations

News and commentary from the endocrinology world

Also in TTHealthWatch: early sugar exposure, hypertension, and diabetes

Labels now caution about pulmonary aspiration risk

Ophthalmologists hope expanded use will lead to more evaluations in primary clinics

Health news and commentary gathered by 麻豆传媒 staff

Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist

Diagnoses were also delayed the longer sugar was restricted

Meta-analysis suggests 24-hour clear liquid diet works to avoid aspiration, even with GLP-1s

News and commentary from the endocrinology world

New guidance replaces earlier rec of a 1-week and 1-day hold of injectable and oral GLP-1 agents

Also in TTHealthWatch: best medications for opioid use disorder